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Relative expression quantitative real-time polymerase chain reaction (RT-qPCR)
experiments are a common means of estimating transcript abundances across biological
groups and experimental treatments. One of the most frequently used expression
measures that results from such experiments is the relative expression ratio (RE), which
describes expression in experimental samples (i.e., RNA isolated from organisms,
tissues, and/or cells that were exposed to one or more experimental or nonbaseline
condition) in terms of fold change relative to calibrator samples (i.e., RNA isolated from
organisms, tissues, and/or cells that were exposed to a control or baseline condition).
Over the past decade, several models of RE have been proposed, and it is now clear that
endogenous reference gene stability and amplification efficiency must be assessed in
order to ensure that estimates of RE are valid. In this review, we summarize key issues
associated with estimating RE from cycle threshold data. In addition, we describe several
methods based on linear modeling that enable researchers to estimate model parameters
and conduct quality control procedures that assess whether model assumptions have
been violated.
KEYWORDS: amplification efficiency, endogenous reference gene, gene expression, linear
regression, real-time quantitative reverse transcription PCR, relative expression ratio

INTRODUCTION
Overview
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is a method of
quantifying transcript abundances that is routinely used to investigate expression in a small to moderate
number of genes. In particular, RT-qPCR is frequently used to confirm microarray results and to
investigate the expression of rare transcripts[1,2,3,4,5,6]. The primary strength of RT-qPCR is that its
large dynamic range makes it well suited for quantifying low abundance transcripts and transcripts that
vary widely in abundance between groups of interest[7,8,9]. Nevertheless, there are a number of
*Corresponding author.
©2011 with author.
Published by TheScientificWorld; www.thescientificworld.com
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difficulties associated with generating high-quality RT-qPCR data. Previous reviews have described many
of these issues, including ensuring that RNA is of a sufficient quality and purity[10,11], the pros and cons
of various approaches to generating cDNA via reverse transcription[7,10,12,13], the importance of proper
sample storage[11], the need for careful primer design and assay validation[11], and the advantages and
drawbacks to different detection chemistries[6,10,14,15]. However, comparatively little effort has been
spent reviewing the issues associated with analysis and quality control of RT-qPCR data.
Over the past decade, a number of statistical and computational approaches to analyzing RT-qPCR
data have been suggested in the literature, and it is now clear that applying objective statistical methods to
RT-qPCR data poses several challenges[8,9,16,17,18]. In this review, we briefly describe the numerical
data generated via most relative expression RT-qPCR experiments and then discuss several practical
issues that researchers conducting relative expression RT-qPCR experiments are likely to face. In
particular, we focus on using linear models for parameter estimation and the evaluation of assumptions
that are inherent to the calculation relative expression ratios (RE). We then conclude by summarizing the
steps involved in processing relative expression RT-qPCR data, briefly discussing the issue of error
propagation – how uncertainty in the parameters used to calculate RE affects the uncertainty of RE itself –
and listing a set of general guidelines for the quality control and analysis of RE values.

The Quantification Cycle: The Central Value of RT-qPCR
The basic strategy underlying RT-qPCR is to record the accumulation of fluorescent dyes that label a
specific nucleic acid product or double-stranded DNA molecule throughout the course of a PCR. The
amount of product yielded by a PCR approximates a logistic (i.e., sigmoidal) curve when it is plotted as a
function of the number of reaction cycles completed (Fig. 1). Thus, setting a threshold within the
exponential phase of the amplification curve and recording the number of fractional cycles required to
eclipse this threshold provides a correlate to the initial amount of template known as the quantification
cycle (Cq; lower Cq values correspond to more starting template). However, while Cq is the value of
interest in the majority of RT-qPCR experiments, its determination requires exclusion of ground phase
cycles (Fig. 1; also known as the background or baseline) and determination of where along the y-axis,
within the exponential phase, the threshold should be placed. Determination of the baseline and threshold
is usually handled by proprietary software that comes with real-time PCR hardware, and different systems
use different methods for baseline and threshold determination. Because this review focuses on how to
analyze Cq values rather than how to ensure they are valid, we do not discuss baseline and threshold
determination further and refer interested readers to Bustin and Nolan[10] and Adams[19] for discussions
of when to adjust the baseline and threshold manually.

The Relative Expression Quantification Strategy
There are two general approaches to conducting RT-qPCR experiments. The first, known as absolute
quantification, is based on calibration to a standard curve generated from a known external source (e.g.,
recombinant DNA) that enables one to express data in terms of transcripts per biological unit (e.g.,
copies/μg of tissue). The second, known as relative quantification, describes expression in arbitrary units
that are based on comparisons to a calibrator sample or a series of calibrator samples (e.g., RNA isolated
from control or unmanipulated sources). Because the relative quantification approach makes fewer
assumptions, is less labor intensive, and is sufficient for most applications, it is the method most
frequently used in basic research and is thus the focus of this review.
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FIGURE 1. An example of a RT-qPCR amplification plot showing the four
phases of a PCR. Dashed lines denote the approximate boundaries of each
phase. The exponential phase is highlighted in gray. Note that the bottom dashed
horizontal line corresponds to the ground phase.

The traditional approach to relative expression RT-qPCR is to plug the relevant Cq values, or their
averages, into one of a number of mathematical models that generate a RE describing expression in
noncalibrator samples in terms of fold change relative to calibrator samples[8]. Usually, RE is normalized
to one or more endogenous reference genes (ERGs)[8] because, in principle, this approach enables one to
correct for variations in the amount and/or quality of the starting template that are introduced during
upstream phases of the workflow[20]. The simplest and most widely used model of RE is known as the
2-ΔΔCt method[21] and can be described by the following equations:
(1)
(2)
(3)
where GOIS = Cq for the gene of interest (GOI) from a noncalibrator sample, ERGS = C q for the ERG
from a noncalibrator sample, GOIC = Cq for the GOI from a calibrator sample, and ERGC = Cq for the
ERG from a calibrator sample. Although this model is popular due to its simplicity, it is based on a
number of assumptions, some of which are more crucial to the inferential conclusions of a study than
others (discussed in the next section). One of the most crucial assumptions is that the ERG being used for
normalization is invariant across the groups being considered. Also of critical importance is that the
reaction efficiencies are equal among the four reactions that are used to calculate R E. Finally, there must
be a doubling of the reaction product following every cycle (i.e., a percentile reaction efficiency [PAE] of
one or a reaction efficiency [E] of two) in order for the 2-ΔΔCt method to estimate the magnitude of RE
accurately. In practice, any combination of these assumptions can be violated, with the end result being an
inaccurate estimate of RE and/or spurious statistical significance[8,18,22,23].
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ADDRESSING ASSUMPTIONS THAT ARE LIKELY TO BE VIOLATED
Endogenous Reference Gene Stability
Perhaps the most critical assumption of all relative expression RT-qPCR analyses is that the ERG used
for normalization is invariant across all of the groups being considered[8,20,22,23]. It has long been
known that assuming that highly expressed ―housekeeping‖ genes are invariant across treatments/groups
is poor practice. Moreover, it is unlikely that any genes are universally suitable as ERGs across all tissues
and research paradigms. Therefore, it is important to verify that ERGs are invariant each time one wishes
to investigate a new experimental system or tissue[7,14,23,24]. However, ERG validation is often
challenging and can become a circular problem because without a way of accounting for the effect of
each RNA sample, it can be difficult to tell whether differences in ERG Cq values are due to differences
among the groups being compared or to the technical variation that one is trying to remove via
normalization[25,26,27].
A widely used approach to ERG validation is implemented by the geNorm software package[25].
Here, it is assumed that candidate ERGs are not coregulated, so that pair-wise calculations between the
candidates based on the set of RNA samples to be compared can be used to arrive at metrics of stability
for each candidate[25]. These metrics are, in turn, used to arrive at a subset of candidate ERGs from
which a normalization factor (NF) based on the geometric mean of the subset is calculated. However, this
so-called pair-wise approach has been criticized by Andersen et al.[26], who put forth a model-based
approach to ERG validation that is implemented by the NormFinder software package. The statistical
model proposed by Andersen et al.[26] is:
(4)
where yigj = the log-transformed expression measure for candidate ERG i in the jth sample of group g, αig
= the effect of candidate ERG i within experimental group g, βgj = the effect of RNA sample j from
experimental group g, and εigj = a random variable (error term) with a mean of zero and variance σ 2. By
using this model as a starting point, Andersen et al.[26] arrived at estimates of intra- and intergroup
variation in gene expression for candidate ERGs, and derived stability values (i.e., metrics) for each
candidate. Andersen et al.[26] compared their approach to the pair-wise approach of Vandesompele et
al.[25], and were able to show that their model-based approach selected ERGs with low intra- and
intergroup variation and was robust to candidate panels in which some of the candidate ERGs were
coregulated. The pair-wise approach, on the other hand, selected sets of ERGs with correlated expression
profiles rather than genes with low intra- and intergroup variation. Thus, in situations where the
expression of candidate ERGs are correlated across groups/treatments, the pair-wise method of
Vandesompele et al.[25] may select ERGs that lead to inaccurate estimates of RE[26].
Although the model-based approach of Andersen et al.[26] is robust with respect to candidate ERG
panels in which some of the genes are coregulated, its validity depends on several assumptions. For
example, the model-based approach assumes that the average expression of the candidate ERGs does not
vary across the groups being considered. To meet this assumption, Andersen et al.[26] originally
demonstrated the model-based approach with candidate ERGs that were carefully selected from
microarray data that suggested that the candidates were stably expressed across the groups of interest.
Thus, in cases where microarray data are not available for candidate ERG identification, it may be
difficult to assess the assumptions of the model-based approach. Hence, when microarray data are not
available ahead of time, the pair-wise method of Vandesompele et al.[25] may be more feasible, provided
that the user is aware of its assumptions and limitations (see above).
To conclude our discussion on ERG stability, we point out that mixed effect models provide a wellestablished framework for modeling correlated data and individual effects[28]. Nevertheless, to the best
of our knowledge, mixed models have not been used to derive statistical tests of ERG stability. However,

1386

Page/Stromberg: Real-Time PCR Analysis and Quality Control

TheScientificWorldJOURNAL (2011) 11, 1383–1393

if we wish to evaluate the suitability of a candidate ERG among g groups and j RNA samples, then
provided that there is sufficient technical replication of Cq for each of the j samples, we can formulate the
following mixed model:
(5)
where yigj = the ith Cq reading from the jth RNA sample in the gth group, β0 = the intercept, Gg = the fixed
effect of the gth group, Ij(Gg) = the random effect of the jth RNA sample nested within the gth group, and
εigj = the error associated with the ith Cq reading from the jth RNA sample in the gth group. Of particular
relevance is that this model allows us to avoid circularity by enabling us to assess whether there is
significant variation in candidate ERG Cq values among groups (i.e., test for statistical significance of the
Gg term) in the presence of parameters that allow for the statistical removal of the effects of individual
RNA samples.

Estimating Reaction Efficiency
Another assumption of the 2-ΔΔCt model that is likely to be violated is the assumption of 100% reaction
efficiency (i.e., E = 2 or PAE = 1) for all of the reactions that are used to calculate RE[18]. While it is
unlikely that any PCR has precisely 100% efficiency, implicit to this assumption is the additional
assumption that all of the reactions used to calculate RE have equal efficiencies. Thus, while situations in
which E differs from two, but is more-or-less equal among the reactions used to calculate RE, will result
in inaccurate estimates of RE, they are not likely to result in erroneous inferences about differences
between groups. However, cases in which the efficiencies of the reactions used to calculate R E are
qualitatively different will lead to poor estimates of RE and may lead to erroneous inferences about
differences between groups. Thus, the assumption of equivalent efficiencies is more critical than the
assumption of 100% reaction efficiency when it comes to determining whether there are differences
among groups. One of the first models to incorporate the concept of reaction efficiency into the
calculation of RE was put forward by Pfaffl[29]. According to Pfaffl[29], the relative expression ratio is:
(6)
where, EGOI = the reaction efficiency of the gene of interest, EERG = the reaction efficiency of the
endogenous reference gene, and GOIC, GOIS, ERGC, and ERGS are as defined above for Eq. 1.
Recently, this model has been expanded by Hellemans et al.[30] to the following form that allows for
multiple ERGs:
(7)

where f = the number of ERGs used for normalization and the remaining variables are as defined for Eq.
6. It is important to note that while these models account for differences in E between the GOI and ERG,
they assume that neither EGOI nor EERG vary between calibrator and noncalibrator samples. As is briefly
discussed below, this assumption may be violated, and methods for assessing whether this is the case
have been presented by Burns et al.[31] and Yuan et al.[17,18].
The introduction of E into relative quantification models means that E must be empirically estimated
in order for these models to be used. The most commonly used approach for doing this is to estimate the
average E from a series of reactions that were set up using a variety of cDNA template concentrations
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(i.e., a dilution series). One can then equate the slope of the linear regression of log10(cDNA
concentration) against Cq to E as follows:
(8)
where m is the slope estimated via linear regression (Fig. 2A)[8,29]. More recently, Yuan et al.[17,18]
suggested estimating the PAE by regressing the log2(cDNA concentration) against Cq as in Fig 2B. E and
PAE can be related by Eq. 9[18].
(9)

FIGURE 2. Various methods of estimating E and PAE. (A) Estimation of E from a dilution
series using the log10(cDNA concentration) method. E is estimated using Eq. 8 (see text). (B)
Estimation of PAE from the same dilution series shown in panel A using the log 2(cDNA
concentration) approach. LCL = lower 95% confidence limit of the slope and UCL = upper 95%
confidence limit of the slope. Note that the estimate of PAE is marginally greater than 1 at the
0.05 level, indicating that this method has overestimated the true value of PAE. (C) A log2
transformation of the amplification plot shown in Fig. 1. The exponential phase of the reaction
consists of cycles 18 through 22 as indicated by the dashed vertical lines. (D) Estimation of PAE
using the exponential phase cycles highlighted in panel C. Note that the estimate of PAE is not
significantly different from 1 at the 0.05 level.
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The advantage of using the approach of Yuan et al.[17,18] is that the slope of the regression can be
interpreted on the raw scale (i.e., PAE = -m, where m is the slope estimated via regression), which, in
turn, leads to straightforward statistical tests of departures from 100% efficiency (i.e., is PAE = -1?) and
differences among samples/groups (i.e., do the slopes estimated from different samples/groups differ from
each other?; also see Burns et al.[31]).
Despite being the most commonly used method, estimating E or PAE from dilution series data has
several drawbacks. Most obviously, the dilution series method requires considerable amounts of RNA and
is laborious. Hence, for large experiments, it may not be feasible to estimate E for every sample and gene
combination. In addition, the dilution series approach does not estimate reaction-specific efficiencies, but
rather the average E across several reactions. Thus, dilution series–based estimations provide no means of
identifying reactions with outlying E values (see below). Finally, dilution series–based methods
occasionally yield estimates of E that are >2, suggesting that they are prone to overestimating E (Fig.
2B)[8].
The second general method for estimating reaction efficiencies is to use the cycle-by-cycle
fluorescence data that are collected during the course of a real-time PCR (Fig. 1). This approach has the
advantage of being able to yield an estimate of the reaction efficiency for every reaction. Furthermore,
unlike the dilution series approach, it does not require additional labor as fluorescence data are acquired
during the course of conducting an experiment. A number of strategies for estimating reaction efficiencies
from fluorescence data have been suggested in the literature. However, the most straightforward
approaches involve identifying the exponential phase of the amplification curve (Fig. 1; see Pierson et
al.[32] and Ramakers et al.[33] for descriptions of algorithms that are useful for automating the process of
identifying the exponential phase), and regressing the resulting log10[32,33] or log2[18] transformed
subset of fluorescence values against cycle number (Fig. 2C,D). The resulting slope of this regression can
be used to obtain an estimate of E or PAE (Fig 2D). As is the case with dilution series data, using the log2
scale has the advantage of yielding estimates of PAE that are interpretable on the raw scale as the slope of
the regression on the log2 scale is itself an estimate of PAE.
While estimating reaction efficiencies from fluorescence data has several advantages over the dilution
series method (see above), there are some drawbacks. An obvious concern is that for large experiments
involving thousands of reactions, using florescence-based approaches creates a considerable informatics
problem. Another concern that arises when using fluorescence-based methods that rely on linear regression
is that the reaction efficiency estimates will be based on small sample sizes due to the exclusion of a large
number of reaction cycles. Finally, it is not clear that using the efficiency estimates generated for every
reaction in a dataset is the most appropriate use of this information as analyzing data based on reactionspecific efficiencies may introduce considerable noise into a dataset[32,34]. Pierson et al.[32] and Cikos et
al.[34] have suggested that analyses based on averaged efficiencies provide more robust results and that
reaction-specific efficiencies should be used primarily to exclude reactions that have outlying efficiencies.
In conclusion to our discussion of efficiency, we note that we have only reviewed strategies that use
linear regression to estimate E or PAE from fluorescence data. Our reason for doing this is that linear
regression is the most conceptually simple approach to estimating reaction efficiencies and is therefore
likely to be the most accessible to practicing biologists with a limited background in statistics. Nevertheless,
several strategies for addressing the issue of reaction efficiency that rely on nonlinear regression have also
been proposed[35,36,37], many of which are implemented by the qpcR software package[38].

STATISTICAL INFERENCE
Conventional Tests and Data Transformation
By far the most common way in which RT-qPCR data are analyzed is via the use of standard parametric
statistical tests (i.e., t-test, ANOVA, etc.) that assess whether RE varies as a function of the
groups/treatments being considered. As described in the previous section, there are a number of situations
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that can render such analyses invalid. Nevertheless, if the assumptions that are essential to calculating
unbiased estimates of RE are met, the application of objective statistical methods to relative expression
RT-qPCR data is valid. When using conventional parametric statistics to evaluate RT-qPCR data, it is
important to bear in mind that RE is not symmetrically scaled as up-regulated values of RE lie on one scale
(1 < RE < ∞) and down-regulated values lie on another scale (1 > RE > 0). We recommend analyzing
log2(RE) because log transformations of RE result in symmetrically scaled expression measures that are
more likely to meet the assumption of normality that is inherent to most parametric models[27]. As shown
in Eq. 3, ΔΔCq lies on the same scale as log2(RE) and thus offers the same advantages.

Permutation Procedures and Linear Models for Comparisons of Two Groups
Although most analyses of relative expression RT-qPCR data use conventional parametric tests, several
authors have suggested RT-qPCR–specific methods for drawing inferences about whether RE (or
transformations thereof) statistically differs between two groups of interest. One of the earliest methods
for doing this was put forward by Pfaffl et al.[39] and is based on a resampling procedure. In this
approach, two biologically replicated groups (i.e., calibrator and noncalibrator) are considered in which
one group consists of n1 samples and the second group consists of n2 samples. For each sample in both
groups, GOI and ERG Cq values are generated (potentially with technical replication) and RE is calculated
according to Eq. 6, using the means of the two respective groups (i.e., calibrator and noncalibrator) for
GOIS, ERGS, GOIC, and ERGC. A large number of pseudosamples (>1000) are then generated by
permutating the group labels of the GOI and ERG readings. RE is then calculated for each pseudosample
and the proportion of pseudosamples with more extreme R E values than the observed RE value is used to
estimate a p value for the null hypothesis that the two groups have an RE of 1 (i.e., log[RE] = 0; see Pfaffl
et al.[39] for additional details).
More recently, Yuan et al.[17,18] proposed a number of ways to estimate and assess the statistical
significance of ΔΔCq using linear models. Particularly noteworthy is that Yuan et al.[18] were able to
demonstrate the flexibility of their approach by presenting methods for estimating an efficiency-adjusted
ΔΔCq (ΔΔCqadj; Eq. 10) based on dilution series data and fluorescence data.

(10)
While a comprehensive review of the methodologies developed by Yuan et al.[17,18] for estimating
and assessing ΔΔCq is beyond the scope of this review, we present one of the models from Yuan et al.[17]
to give a feel for these authors’ approach to assessing statistical significance of RT-qPCR data. Here, we
assume that a researcher wants to assess whether two biologically replicated groups (i.e., calibrator and
noncalibrator) differ in the expression of a GOI that has been normalized to an ERG. Moreover, we
assume that the researcher has generated dilution series data for every calibrator and noncalibrator sample
for both the GOI and the ERG. Once in place, these data can be recoded into four groups such that group
one corresponds to GOI readings from calibrator samples, group two corresponds to GOI readings from
noncalibrator samples, group three corresponds to ERG readings from calibrator samples, and group four
corresponds to ERG readings from noncalibrator samples. An analysis of covariance (ANCOVA) model
of the following form can then be fit to the data:
(11)
where β0 = the intercept, βcon = the effect of template concentration, βgroup = the effect of the grouping
variable described above, βgroupcon = the effect of the interaction between group and concentration, and ε =
the error term. It then follows that contrasting the parameters associated with the βgroup term (i.e., μx below
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where x is one of the four groups described above) according to Eq. 12 results in an estimate of ΔΔCq as
well as a test of the null hypothesis that ΔΔCq = 0.
(12)
The parameters associated with the βgroupcon term are also of interest as they are slopes that describe
how Cq changes as a function of log2(template concentration) for each of the four groups. Thus, the
βgroupcon parameters can be used to test for equal efficiencies among groups and/or to efficiency correct
(see Eq. 10) the ΔΔCq estimate that results from the contrast presented in Eq. 12[18].
While the RT-qPCR specific approaches to inference described above provide explicit statistical
frameworks for interpreting results, they do not, in and of themselves, alleviate the burden of meeting the
assumptions of relative expression models. Therefore, it is still critical to ensure that ERGs are invariant
and that data comply with the assumptions about reaction efficiency made by the model. At present, a
major drawback to many of the RT-qPCR specific statistical tests is that they only allow for comparisons
of two groups. Thus, there is a need for general RT-qPCR–specific statistical frameworks that enable
researchers to assess complex experimental designs, while simultaneously providing tools for inspecting
data quality with respect to the assumptions that are critical to the validity of the method.

DATA PROCESSING, ERROR PROPAGATION, AND RECOMMENDATIONS
It has now been repeatedly demonstrated that the way in which RT-qPCR data are processed and analyzed
can strongly influence the biological conclusions drawn from the data[16,40]. Although a large number of
processing procedures have been described in the literature, there is currently no consensus on which
methods are most robust. The quality control and processing steps that are essential to calculating valid
RE values include baseline determination, threshold determination, control gene validation, efficiency
estimation, and removal of reactions with outlying Cq[31] and/or E values. In addition, if samples from
separate runs (i.e., separate microtiter plates) are to be directly compared, it is likely that some sort of
inter-run calibration will be required[30]. One of the most important issues associated with data
processing that is a source of ongoing research is the issue of error propagation[9,30,41]. Of particular
concern within the context of the approaches to data analysis discussed in this review is that all of the
components needed to calculate RE, such as efficiency estimates and Cq values, are themselves measured
with uncertainty. Although it is common practice to technically replicate Cq values (i.e., taking the
average of several Cq values that were generated from the same RNA sample), the dispersion estimates
(e.g., variance, standard error, etc.) associated with technically replicated Cq values are often not used to
calculate measures of dispersion for RE. Moreover, error propagation with respect to the uncertainty
surrounding efficiency estimates is also frequently lacking. Thus, there is a need to develop processing
procedures that account for this uncertainty as well as user-friendly software implementations of these
procedures that make them readily available to practicing biologists.
When conducting RT-qPCR experiments, one of the first decisions that must be made is which genes
to evaluate for suitability as ERGs. In cases where companion microarray data are available, the modelbased approach of Andersen et al.[26] is well suited for ERG identification. In situations where
companion microarray data are not available, the pair-wise approach of Vandesompele et al.[25] may
enable the identification of ERGs that allow for the calculation of a stable NF. Irrespective of whether a
single ERG or an NF is used for normalization, the mixed model presented in Eq. 5 can be used as a post
hoc assessment of whether the selected ERG or NF is stable across the groups of interest after the effects
of the individual RNA samples have been statistically removed. Once it is clear that the ERG/NF is
indeed stable, the next step is to estimate E or PAE. In our opinion, estimating the PAE from fluorescence
data on the log2 scale according to Yuan et al.[18] offers several advantages. First, unlike the dilution
series method, it does not require additional labor, reagents, and RNA, which may be prohibitive if there
are a large number of samples or GOIs to investigate. Second, linear regression on the log2 scale enables a
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direct estimate of PAE for every reaction as well as a statistical test of whether PAE statistically differs
from one. Third, standard methodologies for comparing the slopes of different regression models[31,42]
can be used to assess whether any of the slopes used to calculate a given RE value statistically differ from
one another. Therefore, one is not forced to make the assumption that EERG and EGOI are equal across the
groups being considered (see Eqs. 6 and 7). Eq. 10 can then be used to calculate ΔΔCqadj. However, the
PAE parameters in this equation should be based on the average PAE for each of the four respective
groups, and reactions with outlying Cq values and/or PAE values should be excluded. In cases where there
are more than two groups to compare, there will be more than one noncalibrator group. Because ΔΔCqadj
lies on the log2 scale, ΔΔCqadj can itself be treated as an expression measure and analyzed using
conventional parametric statistical tests such as ANOVA.
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